This inventor holds 17 USPTO granted patents and 1 published patent application. Top assignees: Somerset Pharmaceuticals, Inc., Dbbh, LLC. Active years: 2000-2022.
Location History:
- Dade City, FL (US) (2000 - 2006)
- Gobles, MI (US) (2000 - 2022)
Company Filing History:
Years Active: 2000-2022
Title: The Innovative Mind of Anthony R. DiSanto
Introduction
Anthony R. DiSanto is a prolific inventor based in Dade City, Florida, who has made significant contributions to the field of pharmaceutical sciences. With a remarkable portfolio of 17 patents, DiSanto's innovations have focused on improving the delivery and efficacy of medications, particularly in the area of antihistamines.
Latest Patents
Among his most recent inventions are two notable patents. The first patent, titled "Intranasally Administered Antihistamines and Uses Thereof," discloses compositions that include diphenhydramine or its pharmaceutically acceptable salts in a liquid vehicle. These compositions can be administered intranasally, providing enhanced plasma and brain concentrations compared to traditional oral administration, while avoiding the complications associated with intravenous methods.
The second patent, "S(+) Desmethylselegiline and Its Use to Treat Narcolepsy," presents novel compositions and methods utilizing the S(+) enantiomer of desmethylselegiline. This innovative approach addresses selegiline-responsive diseases, particularly those tied to neuronal degeneration or trauma, as well as conditions arising from immune dysfunction. The patent outlines effective dosages, ensuring optimal therapeutic outcomes for patients.
Career Highlights
Anthony DiSanto has had a meaningful career, contributing to various pharmaceutical entities. Notably, he has worked with Somerset Pharmaceuticals, Inc. and Dbbh, LLC, where he harnessed his expertise in drug formulation and delivery. His extensive knowledge has placed him in a respected position within the pharmaceutical industry.
Collaborations
Throughout his career, DiSanto has collaborated with esteemed colleagues, including Cheryl D. Blume and John J. Sramek. These collaborations have likely played a pivotal role in the development and refinement of his inventive ideas, fostering an environment for innovation and advancement in medicinal applications.
Conclusion
Anthony R. DiSanto's contributions to pharmaceutical innovation are commendable. With his focus on enhancing medication delivery systems, he has improved the quality of life for many patients in need. As he continues to push the boundaries of scientific inquiry, the medical field eagerly anticipates the impact of his future inventions.